Key result
Tempol lowers MAP by ~57 mmHg and reduces heart rate in hypertensive rats.
Answers are grounded in this paper and cite their sources.
Acute intravenous Tempol reduces mean arterial pressure (MAP) and heart rate (HR) in spontaneously hypertensive rats. We investigated the hypothesis that the antihypertensive action depends on generation of hydrogen peroxide, activation of heme oxygenase, glutathione peroxidase or potassium conductances, nitric oxide synthase, and/or the peripheral or central sympathetic nervous systems (SNSs). Tempol caused dose-dependent reductions in MAP and HR (at 174 micromol/kg; DeltaMAP, -57+/- 3 mmHg; and DeltaHR, -50 +/- 4 beats/min). The antihypertensive response was unaffected by the infusion of a pegylated catalase or by the inhibition of catalase with 3-aminotriazole, inhibition of glutathione peroxidase with buthionine sulfoximine, inhibition of heme oxygenase with tin mesoporphyrin, or inhibition of large-conductance Ca(2+)-activated potassium channels with iberiotoxin. However, the antihypertensive response was significantly (P < 0.01) blunted by 48% by the activation of adenosine 5'-triphosphate-sensitive potassium (K(ATP)) channels with cromakalim during maintenance of blood pressure with norepinephrine and by 31% by the blockade of these channels with glibenclamide, by 40% by the blockade of nitric oxide synthase with N(omega)-nitro-L-arginine methyl ester (L-NAME), and by 40% by the blockade of ganglionic autonomic neurotransmission with hexamethonium. L-NAME and hexamethonium were additive, but glibenclamide and hexamethonium were less than additive. The central administration of Tempol was ineffective. The acute antihypertensive action of Tempol depends on the independent effects of potentiation of nitric oxide and inhibition of the peripheral SNS that involves the activation of K(ATP) channels.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2007) studied Spontaneous hypertension (rat model). Tempol vs. Pharmacological blockade (cromakalim, glibenclamide, L-NAME, hexamethonium, pegylated catalase, 3-aminotriazole, buthionine sulfoximine, tin mesoporphyrin, iberiotoxin) was evaluated on Reduction in mean arterial pressure (MAP) and heart rate (HR) (DeltaMAP -57 +/- 3 mmHg; DeltaHR -50 +/- 4 beats/min, p=<0.01). Intravenous Tempol (174 micromol/kg) reduced MAP by 57±3 mmHg and HR by 50±4 bpm in hypertensive rats, blunted 31-48% by K(ATP), NOS, or ganglionic blockade.
Synapse has enriched 10 related papers. Consider them for comparative context: